World Medicine In The World

World Medicine In The World

Afghanistan

Albania

Azerbaijan

Bosnia and Herzegovina

Cambodia

Chile

Costa Rica

Dominican Republic

Ethiopia

Georgia

Ghana

Guatemala

Hong Kong

Iraq

Kosovo

Libya

Malaysia

Mexico

Mongolia

Mozambique

Nicaragua

North Macedonia

Pakistan

Philippines

Singapore

Sri Lanka

Sudan

Syria

Tunisia

Turkmenistan

Uganda

Venezuela

Yemen

EN Select Language

KK RU

Type the word you want to search for.

MENU

CORPORATE

MESSAGE FROM THE CHAIRMAN
MESSAGE FROM THE VICE CHAIRMAN
GET TO KNOW WM
COMPANIES
- WM OPHTHALMICS
POLICIES
CERTIFICATES
AWARDS
RESPONSIBILITY
NEWS FROM OUR COMPANY

PRODUCTS

MEDICATIONS
MEDICAL DEVICES
FOOD SUPPLEMENTS AND VITAMINS
OUR GLOBAL PRODUCT LIST

PRODUCTION

PRODUCTION FACILITIES
QUALITY CONTROL LABORATORIES
WM CERKEZKOY VIDEO TOUR

WMR&D

WMR&D CENTER
SCIENCE DEPARTMENT
PRODUCT DEVELOPMENT AND TECHNOLOGY TRANSFER
- PRODUCT DEVELOPMENT
- TECHNOLOGY TRANSFER
WMINOLAB

BUSINESS STRATEGY

BUSINESS ETHICS AND STRATEGY
BUSINESS DEVELOPMENT
INTERNATIONAL MARKETS

PRESS

WORLD MEDICINE IN PRESS
- VISUAL PRESS
- PRINTED MEDIA
PRESS RELEASES
PRESS CENTER
CORPORATE VIDEOS

CONTACT

CONTACT US
ADVERSE EFFECT NOTICE
OPINIONS AND SUGGESTIONS
BUSINESS DEVELOPMENT FORM

Home
Medications
DERILAYF

DERILAYF

Back to Products

0.05%, 50 g

Form	Cream
Active Substance	Clobetasone
Presentation	1 tube
Treatment Category	Dermatologicals

SPC

DERILAYF

Important! This section is only intended for medical professionals. If you are not a health care professional, you may click "No" and return to the home page.

Yes No

© 2026 World Medicine

Cookie Policy
PDPL
Privacy Policy
Terms of Use

World Medicine Қазақстан